In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Inverness acquires Acon's rapid diagnostics business

Executive Summary

Resolving all previous patent litigation, immunodiagnostics company Inverness Medical Innovations has acquired the assets of Acon Laboratories' rapid diagnostics division. In 2004, Inverness alleged Acon infringed several of its immunoassay patents, including its consumer pregnancy and ovulation tests.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Includes Contract
    • Includes Earnout
    • Intra-Biotech Deal
    • Payment Includes Cash for Equity
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register